Mercedes Aguirre Lipperheide was born in Getxo (Vizcaya, Spain) in 1966. Following her degree in Marine Biology (University of La Laguna, Tenerife) she went on to do her PhD at Leeds University (Pure & Applied Biology Dpt.- UK, 1993). For 24 years her activities have focused on health-related issues, nutrition and supplementation, with special emphasis on the field of prevention. For the last 10 years she has been leading Nua Biological Innovations SL, a laboratory dedicated to the elaboration of food supplements. She is also involved in applied research projects with public and private institutions and has also been a lecturer in various forums related to the above mentioned fields. She has published 4 books related to these topics (www.mercedesaguirre.com).
Bioinformatics Director at Kanteron Systems, Bioinformatics lecturer at Universidad Católica de Valencia, CEO MGviz Cambridge. He has a PhD in molecular biology and a statistics degree. Former Head of Bioinformatics and Data Analysis at Imegen, and former Head of Bioinformatics at Hospital Clínico Valencia-INCLIVA, he grew as bioinformatician at European Bioinformatics Institute, and did an Human Genetics PostDoc at Wellcome Trust Sanger Institute. He has been also Visiting Research Fellow at the Human and molecular genetics center, Medical College of Wisconsin.
Kanteron Systems Founder & CEO, Guest Lecturer in 60 universities, hacker-hacktivist, serial entrepreneur (x8). Oxford (Computing), MIT (EDP), Harvard (1s Neurobiology), ESADE (Int. Business), University of Valencia (Medical Genomics).
Former Visiting Professor in 2 universities, pro basketball player and member of the European Commission Expert Group on Venture Philanthropy and Social Investments.
Awarded “Frost & Sullivan Technology Innovation Award”, “Mirror Review One of the 30 Most Creative CEOs”, “Best Clinical Scientific presentation at DPA”, “El Mundo Innovation of the Year”, “Microsoft Healthcare Digital Heroe”, “ACQ5 Gamechanger CEO of the Year Award”, “InsightsSuccess One of the 30 Most Valuable Tech Titans”, “Owler’s Best CEO in the Healthcare IT Industry”, “CityAM One of the Hottest 50 Tech Startups Superstars”, “Insightssuccess One of the 30 Most Valuable Tech Titans”…
Attila Csordas has picked the problem of aging and the corresponding project of healthy lifespan extension as his exclusive professional motivation at the age of 14. After starting out as a mitochondrial and stem cell researcher, Attila turned his attention to proteomics and has been working as a proteomics bioinformatician for the past 8 years. During these years he acquired hands-on experience in dealing with ever more complex proteomics datasets. In December 2015 he has founded AgeCurve Limited in Cambridge UK, the first ever startup using direct-to-consumer personal proteomics to provide deep age profiles to end users. Besides the default DTC offering, AgeCurve has already started to work with physicians in order to find a way to help the essential work of clinicians and contribute to longevity medicine.
Elisa Tarazona is a physician specialized in Family and Community Medicine. Thanks to her wide experience in health management, she has held positions such as Head of Primary Healthcare at the Health Department of Hospital La Fe in Valencia, and Deputy Director at the Health Department of Hospital La Ribera in Alzira, where she implemented a Primary and Specialized Healthcare integration model. Previously, she worked as a physician for over 15 years.
She also teaches and has published scientific papers both at a national and international level on healthcare management, alternatives to traditional hospitalization and her Primary and Specialized Healthcare integration model. In addition, she has participated in different national and international forums.
She holds a degree in Medicine by the University of Valencia and a master’s degree in Home Hospitalization by the Valencian School of Health Studies (EVES), she completed the Healthcare Institution Senior Management Programme of IESE Business School, she gained a Diploma in Healthcare Services Management by the Polytechnic University of Valencia, as well as a master’s degree in Healthcare Management by BearingPoint and a Programme for Management Development-PMD by Esade. She is a member of the working group of experts of Foro PPP Infraestructuras for the cooperation between the public and private sector.
PhD in Biology by the University of Valencia. When she became a researcher, she started studying the genetic bases of complex diseases with a special interest in schizophrenia and language disorders, as well as the development of models to study Parkinson’s disease. During that time, she did research stays in the United Kingdom and Germany. She focuses on the applications of genetics to medicine and, since 2014, she works at Medigene Press SL, where she participated in the creation of the professional journal Genética Médica News and the scientific journal Genética Médica y Genómica. She is currently the chief editor of both of them.
In 2003 she received a European PhD degree from the Department of Physiology of the Faculty of Medicine of the University of Valencia. During her PhD, she did a pre-doctoral stay in London at The Centre for Cardiovascular Biology and Medicine in the King’s College of London- During that period she also studied how glutathione is able to modulate telomerase activity, to modify cell cycle related protein expression, and to alter the normal rhythm of cell proliferation. Then she did a post-doctoral stay in the Spanish National Cancer Research Centre (CNIO) in Madrid led by the specialist in telomerase and telomeres María A. Blasco She was also interested in studying new genes related to longevity in collaboration with Dr. Manuel Serrano. In 2005, she joined the Catholic University of Valencia as lecturer, and was in charge of the PhD programme. In 2008, she came back to the University of Valencia and in 2011, she became full professor at the Department of Physiology. Currently, she is interested in factors conferring extreme longevity to centenarians and, together with her research group, she has already found that they are exceptionally well regulated at the mRNA level by microRNAs. Her second line of research is the study of stem cells as a useful tool to regenerate aged tissues.
Mari Carmen Gómez Cabrera
Mari Carmen Gómez Cabrera gained her doctorate from the Department of Physiology of the University of Valencia in 2004 and received a thesis award. She has done 4 stays in foreign centres (The University of Southern California, the University of Wisconsin, the University of Liverpool and the University of Minnesota), where she worked in research groups on skeletal muscle, free radicals and physical exercise. She started working as a teacher in 2000 and is currently a full professor at the Physiology Department of the University of Valencia. Her research covers the study oxidative stress associated with physical exercise and the signalling role of reactive oxygen species in skeletal muscle. She has published more than 90 scientific papers, she is a regular contributor to prestigious international journals and has directed 13 doctoral theses. Her total number of citations is 4,000 and her h-index is 30. She has participated in 25 national research projects (5 of them as Principal Investigator) and 4 European research projects. The recognition of her research work has resulted in international research awards, such as the Catherine Pasquier Award (awarded by the Society for Free Radical Research Europe) and national awards such as the García Blanco Medal.
Dr. Lissette Otero is the Chief Medical Officer and Laboratory Director of Life Length since 2017. She is a Clinical Pathology Specialist with a broad background and laboratory training at La Paz University Hospital in Madrid. Dr. Otero has wide experience as Medical Consultant in molecular diagnosis of sexually transmitted diseases, genetic screening of obesity predisposition, prostate, cervix and breast cancer and prenatal diagnosis. Dr. Otero obtained her MBA at EAE Business School/Barcelona University, Master in Aesthetic and Antiaging Medicine at Universidad Complutense de Madrid, Master in Phlebology and Lymphology at Universidad Internacional de Andalucía and she is accredited as Internal Auditor for ISO 15189:2012 Medical laboratories-Requirements for quality and competence.
Dr. Maria Chatzou, CEO of Lifebit, is a biotech innovator and a proud geek, expert in bioinformatics, medical informatics and high performance computing. She is also a passionate entrepreneur and has founded two companies, Innovation Forum Barcelona and, Techstars-backed Lifebit.
Prior to Lifebit, she was a researcher at the Centre for Genomic Regulation, in Barcelona, where she was designing and deploying tools and methods that facilitate the analysis of Big Biomedical Data, allow for biological discoveries, and promote personalised medicine. She was part of the developing team of Nextflow, a programming framework that is revolutionising the computational analysis of genomic data and setting the foundations for personalised medicine computational analyses.
Maria is also a frequent industry speaker and has spoken in many international conferences on the subjects of docker containers, genomics workflows, the computational challenges of personalised medicine, AI and HPC in genomics, women in leadership, entrepreneurship, science ventures, among many other topics.